Healthcare & Life Sciences

After a painful restructuring, industrial manufacturer NN, Inc. is now exploring a sale. Is this the final step in its transformation or a capitulation?

PSH continues its multi-billion dollar share repurchase strategy to tackle its stubborn stock discount. What does this mean for the fund and its future targets?

Dialed Moods' new sea moss and shilajit gummies enter a booming market. But do the ancient ingredients and modern science justify the industry's latest rush?

PG&E's new grid tech does more than keep lights on; it's a vital upgrade for healthcare resilience, wildfire prevention, and safety in a changing climate.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

As the AI skills gap widens, a new framework aims to move companies from pilot purgatory to true adoption by training everyone, not just tech experts.

Fivetran's new Gartner status reveals a deeper industry shift: the race to build the unified data plumbing that will determine if we can trust AI.

A $2.4B deal for Alphawave IP and a revealing investor filing pull back the curtain on the high-stakes race to build the infrastructure for an AI world.

Recent product recalls reveal deep flaws in our safety systems. What can this teach us about regulating the complex world of medical AI before it's too late?

After years of delays, River Rock Capital Partners has taken over a stalled NC project, betting on unmet demand in one of the state's fastest-growing areas.

Subsense just raised $27M for a BCI delivered via nasal spray. It could democratize neurotech, but what's the cost to our identity and safety?

The CRA's move to digital-first tax filing promises efficiency, but could it block vulnerable Canadians from the very benefits that support their health?

A new pediatric network is betting it can fix fragmented care with integrated tech and a focus on clinicians. Its latest target: Atlanta's crowded market.

A new report reveals the risks of burnout and the strategic value of workforce well-being. For luxury brands and investors, human capital is the new frontier.

Backed by $18M in seed funding, 25-year-old founder Harry Gestetner is launching an AI-powered smart mattress cover to transform longevity through sleep.

Xtant Medical's new nanOss Strata bone graft isn't just an update; it's a strategic move to disrupt the orthobiologics market. Here's why it matters.

A third-generation family takeover, backed by Canada's BDC, positions a 70-year-old firm to accelerate innovation in the competitive medical imaging market.

Abeona Therapeutics' new treatment center for ZEVASKYN marks a strategic leap in gene therapy access, but what does it mean for patients and the market?

As elder isolation becomes a public health emergency in Quebec, one non-profit's strategy of sustained human connection offers a powerful brand lesson.

Fidelity and TIAA still lead, but strategic AI investments are fueling a surge from mid-tier players, redefining the competitive retirement landscape.